Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance
Autor: | Weiyu Chen, Cacang Suarna, Sergey Tumanov, Louise L. Dunn, David E. James, James Cantley, Roland Stocker, Daniel J. Fazakerley, Taqi Shaik |
---|---|
Přispěvatelé: | Fazakerley, Daniel [0000-0001-8241-2903], Apollo - University of Cambridge Repository |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Medicine (General) Bilirubin QH301-705.5 Glucose uptake Clinical Biochemistry Carbohydrate metabolism Biochemistry chemistry.chemical_compound F(2)-isoprostanes Mice Insulin resistance R5-920 Tandem Mass Spectrometry Internal medicine medicine Vitamin E Animals Insulin Biology (General) Mice Knockout F2-Isoprostanes biology Organic Chemistry Biliverdin reductase Fatty liver medicine.disease Lipid oxidation Insulin signaling Fatty Liver Mice Inbred C57BL Insulin receptor Endocrinology chemistry Liver biology.protein Steatosis Insulin Resistance Research Paper Chromatography Liquid |
Zdroj: | Redox Biology Redox Biology, Vol 47, Iss, Pp 102152-(2021) |
Popis: | Background & aims Plasma concentrations of bilirubin, a product of heme catabolism formed by biliverdin reductase A (BVRA), inversely associate with the risk of metabolic diseases including hepatic steatosis and diabetes mellitus in humans. Bilirubin has antioxidant and anti-inflammatory activities and may also regulate insulin signaling and peroxisome proliferator-activated receptor alpha (PPARα) activity. However, a causal link between bilirubin and metabolic diseases remains to be established. Here, we used the global Bvra gene knockout (Bvra–/–) mouse as a model of deficiency in bilirubin to assess its role in metabolic diseases. Approach & results We fed mice fat-rich diets to induce hepatic steatosis and insulin resistance. Bile pigments were measured by LC-MS/MS, and hepatic lipids by LC-MS/MS (non-targeted lipidomics), HPLC-UV and Oil-Red-O staining. Oxidative stress was evaluated measuring F2-isoprostanes by GC-MS. Glucose metabolism and insulin sensitivity were verified by glucose and insulin tolerance tests, ex vivo and in vivo glucose uptake, and Western blotting for insulin signaling. Compared with wild type littermates, Bvra–/– mice contained negligible bilirubin in plasma and liver, and they had comparable glucose metabolism and insulin sensitivity. However, Bvra–/– mice exhibited an inflamed and fatty liver phenotype, accompanied by hepatic accumulation of oxidized triacylglycerols and F2-isoprostanes, in association with depletion of α-tocopherol. α-Tocopherol supplementation reversed the hepatic phenotype and observed biochemical changes in Bvra–/– mice. Conclusions Our data suggests that BVRA deficiency renders mice susceptible to oxidative stress-induced hepatic steatosis in the absence of insulin resistance. Graphical abstract Image 1 Highlights • Low plasma levels of bilirubin associate with increased metabolic disease risk. • A direct link between bilirubin and metabolic disease remains to be established. • Global BVRA deficiency causes global bilirubin deficiency and a fatty, inflamed liver. • This hepatic phenotype is linked to decreased vitamin E and increased lipid oxidation. • Vitamin E supplements restore normal liver phenotype in BVRA deficiency. |
Databáze: | OpenAIRE |
Externí odkaz: |